Cerecor Inc. Class B Warrants

(CERCZ) Trade

By |

Profile

Cerecor Inc is a clinical stage biopharmaceutical company operating in the US. It is engaged in developing drug candidates for patients with neurological and psychiatric disorders. The company holds a portfolio of novel clinical and preclinical compounds for a variety of indications including CERC-301, CERC-501 which is for substance use disorders and adjunctive treatment of MDD and CERC-406 which is preclinical candidate of compounds that inhibit catechol-O-methyltransferase (COMT) within the brain. The company owns a right to COMTi platform which is an enzyme that is critical for the inactivation and metabolism of dopamine.

Contact Information

Website: www.cerecor.com
Email: john.woolford@westwicke.com
Main Phone: +1 410 522-8707
Address: 400 East Pratt Street
Address 2: Suite 606
State: MD
City / Town: Baltimore
Country: USA
Postal Code: 21202

Issuer Information

Exchange: NSC
CEO: Peter S. Greenleaf
Employees: 38
NAICS: Pharmaceutical Preparation Manufacturing(325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 1.03 52 Wk Low 0.0114
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange NCM